share_log

和鉑醫藥-B：自願公佈 - 執行董事自願禁售承諾

HBM HOLDINGS-B: VOLUNTARY ANNOUNCEMENT - VOLUNTARY LOCK-UP UNDERTAKING BY EXECUTIVE DIRECTOR

Hong Kong Stock Exchange ·  Apr 17 16:30
Summary by Futu AI
和鉑醫藥控股有限公司（「和鉑醫藥-B」）於2024年4月17日宣佈，執行董事、行政總裁兼董事會主席王勁松博士自願承諾在至少六個月內不會出售其直接或間接持有的公司股份。此舉顯示王勁松對和鉑醫藥的未來前景及長遠發展持樂觀態度。
和鉑醫藥控股有限公司（「和鉑醫藥-B」）於2024年4月17日宣佈，執行董事、行政總裁兼董事會主席王勁松博士自願承諾在至少六個月內不會出售其直接或間接持有的公司股份。此舉顯示王勁松對和鉑醫藥的未來前景及長遠發展持樂觀態度。
WO PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (“WA PLATINUM PHARMACEUTICAL-B”) ANNOUNCED ON 17 APRIL 2024 THAT ITS EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF DIRECTORS, DR. WANG JINSONG VOLUNTARILY UNDERTOOK NOT TO SELL SHARES OF HIS DIRECTLY OR INDIRECTLY HELD COMPANY FOR AT LEAST SIX MONTHS. This move shows that Wang Jinsong is optimistic about the future prospects and long-term development of platinum medicine.
WO PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (“WA PLATINUM PHARMACEUTICAL-B”) ANNOUNCED ON 17 APRIL 2024 THAT ITS EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF DIRECTORS, DR. WANG JINSONG VOLUNTARILY UNDERTOOK NOT TO SELL SHARES OF HIS DIRECTLY OR INDIRECTLY HELD COMPANY FOR AT LEAST SIX MONTHS. This move shows that Wang Jinsong is optimistic about the future prospects and long-term development of platinum medicine.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.